WST logo

WEST PHARMACEUTICAL SERVICES

WSTNYSE
๐Ÿ† #423 by market capEarnings Oct 22US Equity
$351.37โ–ผ $0.77 (โˆ’0.22%)
๐ŸŒ™ After hours$351.37โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ผ 0.2%
7dโ–ฒ 0.1%
14dโ–ฒ 4.1%
30dโ–ผ 2.3%
1yโ–ฒ 46.4%
๐ŸฆMarket Cap
$24.73B
Mid Cap
๐Ÿ“ˆRevenue Growth (YoY)
+12.4%
Healthy
๐Ÿ“ŠGross Margin
36.8%
Healthy
๐Ÿ’ตFCF Margin
13.1%
Healthy
โš–๏ธP/S Ratio
7.5x
Fair
Otter Score
44
Weak

Trading Snapshot

Day Range
$346.81 โ€“ $357.88
52-Week Range
$223.83 โ€“ $386.00
Volume
$3.15B
Avg Volume
$2.65B
Shares Outstanding
70.4M
Next Earnings
Oct 11, 2026

Fundamentals Snapshot

Annual Revenue
$3.07B
Last Q Revenue
$872M
P/E Ratio
44.1
P/S Ratio
7.5x
EPS (TTM)
$7.82
Dividend Yield
0.25%

Why Investors Own WST

  • โœ“High-growth profile โ€” revenue up -3.0% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 55% gross margin and 29% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$3.07Bโ–ผ โˆ’3.7% YoY
Gross Margin (TTM)
54.7%โ–ฒ +3.8% YoY
Operating Income (TTM)
$443Mโ–ผ โˆ’3.7% YoY
Free Cash Flow (TTM)
$898Mโ–ผ โˆ’3.7% YoY

About WEST PHARMACEUTICAL SERVICES

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith โ€“ a cyclic olefin polymer used in vials, syringes, and cartridges โ€“ and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
44/100

Analyst Ratings

โ“˜
Consensus
Buy
23 analysts
Strong Buy7
Buy14
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates